Palbokin (Palbociclib) 125mg

Introduction to Ibrance (Palbociclib) 125mg 

Ibrance (Palbociclib) 125mg is a targeted prescription medicine used in the treatment of certain types of breast cancer, particularly hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. This medicine belongs to a specialized group of oncology drugs that work by slowing down the growth and spread of cancer cells.
Palbokin (Palbociclib) 125mg is classified under Prescription Medicines, Oncology Medicines, Anticancer Drugs, and Targeted Cancer Therapies. It contains Palbociclib, which works by blocking specific proteins responsible for cancer cell division.
In some markets, Palbokin 125mg is available as a generic version containing the same active ingredient Palbociclib, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.

What Is Ibrance (Palbociclib) 125mg? 

Ibrance is the original brand name for Palbociclib, an oral medication widely used for treating advanced breast cancer.
Palbociclib belongs to a class of medicines known as Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors. These drugs help stop cancer cells from dividing and multiplying.
Generic versions such as Palbokin 125mg contain the same active compound and may be used depending on physician recommendation and regional availability.

Drug Class and Mechanism of Action 

Palbociclib is classified as a targeted anticancer agent with strong antineoplastic properties.

How Palbociclib Works 

It works in several ways:

• Inhibits CDK4 and CDK6 enzymes responsible for cell cycle progression
• Blocks cancer cells from transitioning from G1 to S phase
• Slows or stops tumor cell proliferation

Through these mechanisms, Palbociclib helps control cancer progression.

How Ibrance Works in the Body 

Cancer cells divide uncontrollably. Palbociclib helps regulate this by targeting proteins that control cell division.

Key Actions of Palbociclib 

• Stops abnormal cancer cell growth
• Enhances effectiveness of hormone therapy
• Helps maintain disease control in advanced breast cancer

Generic versions such as Palbokin deliver the same active compound, allowing similar targeted treatment when prescribed appropriately.

Medical Uses of Ibrance (Palbociclib) 125mg 

Palbokin 125mg is widely prescribed for specific breast cancer conditions.

Palbociclib for Breast Cancer 

It is mainly used in combination with aromatase inhibitors or fulvestrant in HR-positive, HER2-negative breast cancer.

Potential Benefits 

• Improves progression-free survival
• Delays disease worsening
• Enhances response to hormonal therapy

Generic alternatives like Palbokin 125mg may also be used under medical supervision.

Who Can Take Palbokin 125mg? 

Because Palbociclib is a potent medicine, treatment should always be supervised by a healthcare professional.

Eligibility Criteria 

Patients may be prescribed Palbokin if they:

• Have HR-positive, HER2-negative advanced or metastatic breast cancer
• Are eligible for hormone-based therapy
• Have adequate baseline blood counts

Who Should Avoid Ibrance (Palbociclib) 125mg 

Palbociclib should NOT be used by:

• Pregnant women or those planning pregnancy
• Individuals allergic to Palbociclib
• Patients with severe neutropenia unless monitored

Ibrance (Palbociclib) 125mg Dosage and Administration 

Standard Dosage Guidelines 

Typical dosage recommendations include:

• Palbokin 125mg once daily
• Taken for 21 days followed by 7 days off (28-day cycle)
• Capsules should be swallowed whole
• Usually taken with food

Dosage Adjustments 

Doctors may adjust the dose based on:

• Blood counts (neutropenia risk)
• Liver function
• Patient tolerance and response

Side Effects of Ibrance (Palbociclib) 125mg

Like all cancer medicines, Palbociclib may cause side effects.

Common Side Effects 

• Fatigue
• Nausea
• Hair thinning
• Mouth sores

Serious Side Effects 

• Neutropenia (low white blood cells)
• Increased infection risk
• Liver abnormalities

Patients should seek medical attention if serious symptoms occur.

Storage:
Store below 25°C in a cool, dry place. Protect from moisture and sunlight. Keep out of reach of children.

Frequently Asked Questions (FAQs) 

1. Is Palbociclib 125mg safe for long-term use? 

It may be used long-term under strict medical supervision if effective and well tolerated.

2. Why combine Palbociclib with hormone therapy? 

It improves treatment outcomes by blocking cancer cell division alongside hormonal control.

3. Is Palbociclib chemotherapy? 

No, it is a targeted CDK4/6 inhibitor, not traditional chemotherapy.

4. Can patients donate blood during treatment? 

No, blood donation should be avoided during and shortly after treatment.

5. Can pregnant women take Palbokin 125mg? 

No, it can cause harm to the fetus and must be avoided.

6. Is Palbokin 125mg the same as Ibrance? 

Palbokin contains Palbociclib, the same active ingredient found in Ibrance.

7. Is a prescription required? 

Yes, it is a prescription-only medicine.

Medical Disclaimer 

Disclaimer:
This information is for educational purposes only and should not be considered medical advice. Palbociclib is a prescription-only medicine and must be used under the supervision of a qualified healthcare professional.